Over the last few years, the cannabis sector has been the place to be for stock investors. It is undoubtedly one of the hottest markets around, with a May 2019 report expecting the cannabis market to be worth USD $66.3 billion by 2025 . At the same time, investing in a ...
Stockhouse Editorial
|
July 29, 2019
|
Investors are getting excited over a radical new farming technology that is making waves in the media, and in the market. Omri Wallach of Stockhouse Media was recently joined by Michael Collinson, Chairman of the company behind the technology, Bee Vectoring...
Omri Wallach
|
November 5, 2019
|
The bloom and boom are back in the cannabis sector. Cannabis is now legal in 10 U.S. states, including recently in Illinois. Activists and legislators are working hard to get it legalized in more states with the possibility that it will become legal in Connecticut, Minnesot...
Dave Jackson
|
April 1, 2021
|
Imagine a world where crop yields are always thriving. Imagine a world where disease and pests are managed with a completely natural innovative solution. Imagine a world where a nature takes care of healthy, thriving crops. Well, that world and those solutions are not as fa...
Dave Jackson
|
September 30, 2020
|
The rich are getting richer and the poor are getting poorer, and for that we can largely blame policies of envy that increasingly restrict investors’ access to wealth-building instruments. Case in point: I was recently invited to participate in a pri...
Frank Holmes
|
October 15, 2019
|
Stock investing can be exciting, but it shouldn’t be a rollercoaster ride for investors. If you know how to read company reports, basis spreadsheets, and what financial measures to review, you’re more likely to pick a winning stock. Staying up...
Stockhouse Editorial
|
June 4, 2019
|
Teaser: Let’s face it, we live in a world of radical uncertainty. Yet we’re supposed to make perfectly rational decisions – so, how do we cope with the unknown? We tell narratives, and form our decisions around them! Let’s...
Arkadiusz Sieron
|
December 2, 2019
|
Newark, Calif.-based Protagonist Therapeutics' shares traded 70% higher today after the firm reported preliminary Phase 2 results for Hepcidin Mimetic PTG-300 in the treatment of transfusion dependent beta-thalassemia. Clinical-stage biopharmaceutical company Protago...
Streetwise Reports
|
December 5, 2019
|
So far in 2020, the yield on the 10-year Treasury has averaged an anemic 0.01 percent when adjusted for inflation. Since the end of January, it’s actually dipped below 0 percent, trading as low as negative 0.14 percent on January 31. What this means is...
Frank Holmes
|
February 18, 2020
|
How Moderna uses and benefits from digitization and artificial intelligence are described in a ROTH Capital Partners report. In a March 5 research note, ROTH Capital Partners analyst Yasmeen Rahimi reported that a site visit to Moderna Inc.'s (MRNA:NASDAQ) ...
Streetwise Reports
|
March 9, 2020
|